Gene: YIPF3
Official Full Name: Yip1 domain family member 3provided by HGNC
Gene Summary: Predicted to be involved in cell differentiation. Located in Golgi apparatus and transport vesicle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28736 | YIPF3 Knockout cell line (HeLa) | Human | YIPF3 | 1:3~1:6 | Negative | Online Inquiry |
KO28737 | YIPF3 Knockout cell line (HCT 116) | Human | YIPF3 | 1:2~1:4 | Negative | Online Inquiry |
KO28738 | YIPF3 Knockout cell line (HEK293) | Human | YIPF3 | 1:3~1:6 | Negative | Online Inquiry |
KO28739 | YIPF3 Knockout cell line (A549) | Human | YIPF3 | 1:3~1:4 | Negative | Online Inquiry |
YIPF3 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the YIPF3 gene, a member of the Yip1-like family involved in various cellular processes, including membrane trafficking and lipid metabolism. These cell lines have been generated using CRISPR/Cas9 technology, enabling precise deletions of the YIPF3 gene, which allows for the exploration of its functional consequences in cellular contexts.
Functionally, the YIPF3 Gene Knockout Cell Lines serve as invaluable tools in elucidating the biological pathways influenced by YIPF3. Researchers can leverage these cell lines to investigate the impact of YIPF3 deletion on cellular dynamics, such as endosome trafficking, protein sorting, and lipid homeostasis. The ability to manipulate and observe these pathways in a controlled environment paves the way for significant insights into the gene's role in health and disease.
The scientific importance of these knockout cell lines extends to various fields, including cancer research, neurobiology, and cellular metabolism. By providing a platform to study the downstream effects of YIPF3 inhibition, these cell lines can lead to novel therapeutic targets and strategies for treating diseases related to membrane trafficking disorders.
One unique selling point of our YIPF3 Gene Knockout Cell Lines is their high specificity and efficiency compared to traditional knockout methods. The use of CRISPR/Cas9 not only ensures a targeted approach but also minimizes off-target effects, providing researchers with reliable and reproducible results. Moreover, these cell lines are easy to culture and are compatible with various screening and assay formats, streamlining experimental workflows.
For researchers and clinicians engaged in mechanistic studies or therapeutic development, the YIPF3 Gene Knockout Cell Lines represent a valuable asset. They not only enhance our understanding of fundamental biological processes but also contribute to the broader quest for innovative treatments. As a leader in the development of cutting-edge biological products, our company is committed to providing high-quality research tools that empower scientific advancement and lead to breakthroughs in understanding cellular functions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.